GMYPX
Price
$17.67
Change
-$0.09 (-0.51%)
Updated
Sep 5 closing price
Net Assets
435.35M
RMFCX
Price
$60.45
Change
+$0.07 (+0.12%)
Updated
Sep 5 closing price
Net Assets
109.34B
Interact to see
Advertisement

GMYPX vs RMFCX

Header iconGMYPX vs RMFCX Comparison
Open Charts GMYPX vs RMFCXBanner chart's image
Goldman Sachs Large Cap Value P
Price$17.67
Change-$0.09 (-0.51%)
VolumeN/A
Net Assets435.35M
American Funds American Mutual R3
Price$60.45
Change+$0.07 (+0.12%)
VolumeN/A
Net Assets109.34B
GMYPX vs RMFCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GMYPX vs. RMFCX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMYPX is a Buy and RMFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 109B vs. GMYPX (435M). RMFCX (1.24) and GMYPX (1.21) have matching dividends . GMYPX was incepted earlier than RMFCX: GMYPX (7 years) vs RMFCX (23 years). RMFCX (0.91) and GMYPX (0.88) have similar cost to investors . GMYPX is a more actively managed with annual turnover of: 51.00 vs. RMFCX (31.00). GMYPX has a lower initial minimum investment than RMFCX: GMYPX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 7.71 vs. GMYPX (-1.36). RMFCX return over 5 years is better than : 56.41 vs. GMYPX (29.30).
GMYPXRMFCXGMYPX / RMFCX
Total Expense Ratio0.690.9176%
Annual Report Gross Expense Ratio0.880.9197%
Fund Existence7 years23 years-
Gain YTD6.12611.42154%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets435M109B0%
Annual Yield % from dividends1.211.2498%
Returns for 1 year-1.367.71-18%
Returns for 3 years18.0532.1656%
Returns for 5 years29.3056.4152%
Returns for 10 yearsN/A91.12-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BTAI3.790.22
+6.16%
BioXcel Therapeutics Inc
CAN0.710.02
+3.26%
Canaan
TECH54.411.49
+2.82%
Bio-Techne Corp
KMT21.950.12
+0.55%
Kennametal
HSPOU12.21N/A
N/A
Horizon Space Acquisition I Corp